Jasper Therapeutics (JSPR) Net Shares Issued and Repurchased (2021 - 2025)

Jasper Therapeutics has reported Net Shares Issued and Repurchased for 5 years, with the latest figure at $1.3 million in Q4 2025.

• On a quarterly basis, Net Shares Issued and Repurchased rose 81.62% year-over-year to $1.3 million in Q4 2025; TTM through Dec 2025 was $1.3 million, a 81.62% increase from a year earlier, with the FY2025 full-year figure at $1.3 million, up 81.62% from the prior year.
• Net Shares Issued and Repurchased was $1.3 million for Q4 2025 at Jasper Therapeutics, up from $609700.0 in the prior quarter.
• The five-year high for Net Shares Issued and Repurchased was $3.3 million in Q1 2022, with the low at $5000.0 in Q4 2022.
• Average Net Shares Issued and Repurchased over 5 years is $783912.0, with a median of $603054.0 recorded in 2023.
• The largest YoY upside for Net Shares Issued and Repurchased was 11961.08% in 2023 against a maximum downside of 98.47% in 2023.
• Over 5 years, Net Shares Issued and Repurchased stood at $145753.0 in 2021, then sank by 96.57% to $5000.0 in 2022, then surged by 11961.08% to $603054.0 in 2023, then rose by 15.88% to $698817.0 in 2024, then soared by 81.62% to $1.3 million in 2025.
• The last three Net Shares Issued and Repurchased figures came in at $1.3 million (Q4 2025), $609700.0 (Q1 2025), and $698817.0 (Q4 2024), per Business Quant data.